New Loxo@Lilly facility brings oncology R&D to Louisville

LOUISVILLE — About three years after pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) acquired Loxo Oncology Inc. in a deal worth about $8 billion, the merged companies stepped into the spotlight Thursday with the grand opening of Loxo@Lilly, Lilly’s oncology business unit that’s housed in a gleaming new space in Louisville’s Colorado Technology Center. 

The new facility, built and designed by Whiting-Turner Contracting Co. and CPG Architects, totals 115,000 square feet and is home to about 150 employees, many of whom are scientists researching and developing cancer treatments such as the lung-cancer therapy Retevmo.

“This is a facility where scientists…